跳至主要内容
临床试验/NCT03601546
NCT03601546已完成不适用

Feasibility of Implementing a Cohort of People Living With Hepatitis C in the Viet Tiep Hospital in Hai Phong, Vietnam

Centre Hospitalier Universitaire de Nīmes4 个研究点 分布在 2 个国家目标入组 300 人开始时间: 2018年9月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
300
试验地点
4
主要终点
Lost to follow-up rate

研究概览

简要总结

The purpose of this study is to evaluate the feasibility of implementing a cohort of patients with Hepatitis C in order to generate a larger cohort for future studies

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The patient must have given their free and informed consent and signed the consent form
  • The patient is at least 18 years old
  • The patient is HCV RNA positive

排除标准

  • 未提供

结局指标

主要结局

Lost to follow-up rate

时间窗: Month 12

Patient inclusion rate

时间窗: End of study: 12 months

Number of patients included/number of eligible patients

Rate of missing data of patient variables

时间窗: Day 0-1

Current treatment, introduction of treatment, viral load, HCV genotype, fibrosis stage, HIV co-infection, drug consumption, alcohol consumption, methadone treatment,

Archival of all signed consent forms

时间窗: End of study: Month 12

次要结局

  • initial HCV viral load,(Day 0)
  • HIV viral load(Day 0)
  • Transaminase levels(Day 0)
  • drug and alcohol consumption,(Day 0)
  • Lymphocyte T4 level(Day 0)
  • Early viral response(Week 4)
  • treatment at inclusion(Day 0)
  • commencement of treat(Day 1)
  • HCV genotype(Day 0)
  • Type of treatment(Day 0)
  • Access to health cover(Day 0)
  • Social-demographic characteristics of patients at inclusion(Day 0)
  • Fibrosis stage(Day 0)
  • Hepatic ultrasound(Day 0)
  • Methadone treatment(Day 0)
  • Hepititis B co-infection(Day 0)
  • Commencement of treatment(Day 1)
  • Treatment side effects(ay)
  • Risk factors associated with reinfection(3 months after clearance)
  • HIV co-infection(Day 0)
  • Sustained viral response(Week 12)
  • HCV re-infection(Month 12)

研究者

发起方
Centre Hospitalier Universitaire de Nīmes
申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验